cl report broadli in-line quarter modest miss revenu estim
off-set better expect adjust ebitda mm ahead
forecast il adult use dispensari set open start cl
addit licens chicago expect transform year
 solid sequenti growth oper dispensari cl deliv healthi
sequenti growth quarter led growth compani wholesal busi
account sale growth retail wholesal continu
grow percentag sale remain construct cl revenu manag
strategi continu believ over-index wholesal prove margin
accret long term said compstore basi store
system month grew revenu impress yoy
 healthi underli gross margin expans oper gross margin
came bp lower qoq encourag underli trend note
invest brand awar ca drove declin wholesal revenu
state doubl qoq importantli manag comment oper gross
margin expand bp qoq il az respect effort reduc
overal cost per gram prove effect ultim cl long-term goal cpg-like gross
margin gone unchang clear path get
cogniz variou factor could provid near term disrupt primarili
includ supply-demand imbal il drive sourc acquisit
 repriorit busi model cl announc morn walk
away vidacann acquisit fl cl clearli focus top two prioriti
market il launch adult use sale januari pa
proven vibrant medic market cl domin wholesal share
beyond two core state remain optimist cl prospect ca given earli
wholesal improv origin hous acquisit expect close
earli cl also came across bullish around prospect adult use legal
ny consist repriorit cl also demonstr increas
level focu flexibl around capit rais alloc three sale lease-
back execut well purpose-driven capital-expenditure go larg toward il
 updat estim hold pt steadi despit revenu miss leav
top line estim larg unchang balanc unexpect
delay new pa dispensari open addit ny revenu given valley ag
offici close remind model outstand proven use
deal get renegoti termin howev conserv temper
ebitda estim given previou commentari around potenti gross margin disrupt
il adult use sale ramp new busi get consolid continu model
mm revenu coupl mm mm
adj ebitda prev mm mm impli adj
ebitda margin year come away posit cl focus strategi
attract profit growth opportun pt unchang impli ev/
fy revenu multipl rel estim maintain outperform
pleas see page report import disclosur
outperform rate cresco lab cl cl well posit capit
multipl catalyst includ robust expect growth home market il
especi given adult use sale set begin jan well potenti close
certain transform acquisit robust organ revenu growth outlook coupl
prudent spend drive bottom line profit make cl attract valu proposit
investor look financi prudenc within cannabi space
heal health tryke
 chronic pain ad qualifi
condit il
 organ net sale growth
 revenu growth come
 faster expect close pend
 greater expect gross margin
 higher expect ebitda
 revenu growth come
 longer expect close pend
 lower expect gross margin
 lower expect ebitda
found chicago-bas cresco lab multi-st oper serv
medic adult use cannabi market compani oper dispensari util
hous brand cresco remedi reserv mindi artisan edibl among
other address consum need across differ market segment
compani report cowen compani
profit biolog cost gross fv biolog incom biolog incom oper incom expens invest incom non-control cowen
cannabi valuat methodolog primarili base rel ev-to-sal ev-to-sal
divid sales-growth follow ev-to-sal
cannabi cannabi emerg industri subject regulatori headwind
popul favor legal state thu far
legal cannabi recreat use product remain illeg feder level
look forward much work chang still need occur order industri
realiz full potenti
risk pertain cannabis-rel compani consid invest
 compani connect cannabi industri awar cannabis-rel
compani may risk feder and/or state crimin prosecut depart
treasuri issu guidanc control substanc act csa make illeg
 feder law manufactur distribut dispens cannabi cannabis-rel
product mani state impos enforc similar prohibit notwithstand feder
ban howev mani state district columbia legal certain cannabis-
risk pertain canadian cannabis-rel compani canada cannabi
emerg industri subject regulatori headwind medic adult-us
cannabi legal canada categori subject number potenti headwind
includ tax restrict form factor packag
believ cl well posit compet cannabi market
neg risk revenu profit perform expect driven
geograph risk smaller geograph footprint rel peer result outsiz risk
regulatori fundament perspect
california perform expect california repres key market cl
failur issu legal licens provid better regulatori framework crack
robust illicit market limit upsid state offer
pend failur close one acquisit expect help
compani scale expand geograph presenc
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock cresco lab brown-forman sundial grower secur
cowen compani llc manag co-manag public offer sundial grower past month
cowen compani llc receiv compens invest bank servic sundial grower past month
sundial grower past month client cowen compani llc cowen compani llc provid provid invest bank servic
past month
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc novemb et dissemin novemb et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
